These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16514790)

  • 1. Treatment of adductor-type spasmodic dysphonia by surgical myectomy: a preliminary report.
    Koufman JA; Rees CJ; Halum SL; Blalock D
    Ann Otol Rhinol Laryngol; 2006 Feb; 115(2):97-102. PubMed ID: 16514790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial thyroarytenoid myectomy: an animal study investigating a proposed new treatment for adductor spasmodic dysphonia.
    Genack SH; Woo P; Colton RH; Goyette D
    Otolaryngol Head Neck Surg; 1993 Mar; 108(3):256-64. PubMed ID: 8464639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transoral approach to laser thyroarytenoid myoneurectomy for treatment of adductor spasmodic dysphonia: short-term results.
    Su CY; Chuang HC; Tsai SS; Chiu JF
    Ann Otol Rhinol Laryngol; 2007 Jan; 116(1):11-8. PubMed ID: 17305272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lateral Cricoarytenoid Release: Development of a Novel Surgical Treatment Option for Adductor Spasmodic Dysphonia in a Canine Laryngeal Model.
    Park AM; Paniello RC
    Ann Otol Rhinol Laryngol; 2016 Sep; 125(9):746-51. PubMed ID: 27257292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact in vocal quality in partial myectomy and neurectomy endoscopic of thyroarytenoid muscle in patients with adductor spasmodic dysphonia.
    Tsuji DH; Chrispim FS; Imamura R; Sennes LU; Hachiya A
    Braz J Otorhinolaryngol; 2006; 72(2):261-6. PubMed ID: 16951863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional significance of arytenoid adduction with the suture attaching to cricoid cartilage versus to thyroid cartilage for unilateral paralytic dysphonia.
    Su CY; Tsai SS; Chuang HC; Chiu JF
    Laryngoscope; 2005 Oct; 115(10):1752-9. PubMed ID: 16222189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
    Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
    J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Features of Vocal Fold Adductor Paralysis and the Management of Posterior Muscle in Thyroplasty.
    Konomi U; Tokashiki R; Hiramatsu H; Motohashi R; Sakurai E; Toyomura F; Nomoto M; Kawada Y; Suzuki M
    J Voice; 2016 Mar; 30(2):234-41. PubMed ID: 26183535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
    Rojas GVE; Ricz H; Tumas V; Rodrigues GR; Toscano P; Aguiar-Ricz L
    J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transoral laser ventricular fold resection and thyroarytenoid myoneurectomy for adductor spasmodic dysphonia: long-term outcome.
    Su CY; Lai CC; Wu PY; Huang HH
    Laryngoscope; 2010 Feb; 120(2):313-8. PubMed ID: 20013850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spasmodic dysphonia combined with insufficient glottic closure by phonation.
    Kaszás Z; Lichtenberger G; Mészáros K; Falvai J
    Eur Arch Otorhinolaryngol; 2003 Sep; 260(8):418-20. PubMed ID: 12709812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Comparison of Thyroarytenoid Muscle Myectomy and Type II Thyroplasty for Spasmodic Dysphonia.
    Nomoto M; Tokashiki R; Hiramatsu H; Konomi U; Motohashi R; Sakurai E; Toyomura F; Ueda Y; Inoue S; Tsukahara K; Suzuki M
    J Voice; 2015 Jul; 29(4):501-6. PubMed ID: 25737474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new paramedian approach to arytenoid adduction and strap muscle transposition for vocal fold medialization.
    Su CY; Lui CC; Lin HC; Chiu JF; Cheng CA
    Laryngoscope; 2002 Feb; 112(2):342-50. PubMed ID: 11889395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of recurrent laryngeal nerve resection for adductor spasmodic dysphonia.
    Fritzell B; Hammarberg B; Schiratzki H; Haglund S; Knutsson E; Mårtensson A
    J Voice; 1993 Jun; 7(2):172-8. PubMed ID: 8353632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of factors affecting botulinum toxin results in spasmodic dysphonia.
    Inagi K; Ford CN; Bless DM; Heisey D
    J Voice; 1996 Sep; 10(3):306-13. PubMed ID: 8865102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
    Kendall KA; Leonard RJ
    J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective lateral laser thyroarytenoid myotomy for adductor spasmodic dysphonia.
    Hussain A; Shakeel M
    J Laryngol Otol; 2010 Aug; 124(8):886-91. PubMed ID: 20426891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
    Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
    J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adductor spasmodic dysphonia: Botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective.
    Schuering JHC; Heijnen BJ; Sjögren EV; Langeveld APM
    Laryngoscope; 2020 Mar; 130(3):741-746. PubMed ID: 31169922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.